Q4 2014 13F Holders as of 31 Dec 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
194M
-
Number of holders
-
280
-
Total 13F shares, excl. options
-
164M
-
Shares change
-
+4.39M
-
Total reported value, excl. options
-
$12B
-
Value change
-
+$345M
-
Put/Call ratio
-
2.19
-
Number of buys
-
166
-
Number of sells
-
-99
-
Price
-
$73.11
Significant Holders of INCYTE CORP - COMMON STOCK (INCY) as of Q4 2014
329 filings reported holding INCY - INCYTE CORP - COMMON STOCK as of Q4 2014.
INCYTE CORP - COMMON STOCK (INCY) has 280 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 164M shares
of 194M outstanding shares and own 84.93% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (20.2M shares), WELLINGTON MANAGEMENT GROUP LLP (17M shares), Capital World Investors (16.9M shares), BAKER BROS. ADVISORS LP (14.8M shares), VANGUARD GROUP INC (9.22M shares), JENNISON ASSOCIATES LLC (7.18M shares), BB Biotech AG (4.05M shares), Artisan Partners Limited Partnership (3.82M shares), BlackRock Institutional Trust Company, N.A. (3.73M shares), and Capital International Investors (3.63M shares).
This table shows the top 280 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.